DrugPatentWatch Database Preview
CUBICIN RF Drug Profile
When do Cubicin Rf patents expire, and when can generic versions of Cubicin Rf launch?
This drug has thirty patent family members in nineteen countries.
The generic ingredient in CUBICIN RF is daptomycin. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the daptomycin profile page.
Summary for CUBICIN RF
| International Patents: | 30 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 9 |
| Clinical Trials: | 8 |
| Patent Applications: | 2 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | CUBICIN RF at DailyMed |
Pharmacology for CUBICIN RF
| Ingredient-type | Lipopeptides |
| Drug Class | Lipopeptide Antibacterial |
Medical Subject Heading (MeSH) Categories for CUBICIN RF
Synonyms for CUBICIN RF
| 103060-53-3 |
| Cidecin |
| CS-1857 |
| Cubicin |
| Cubicin (TN) |
| D01080 |
| D4229 |
| Dapcin |
| Daptomicina |
| Daptomicina [Spanish] |
| DAPTOMYCIN |
| Daptomycin (JAN/USAN/INN) |
| Daptomycin for injection |
| Daptomycine |
| Daptomycine [French] |
| Daptomycinum |
| Daptomycinum [Latin] |
| Deptomycin |
| HY-B0108 |
| LY 146032 |
| LY-146032 |
| LY146032 |
| MK-3009 |
| MolPort-046-033-485 |
| NWQ5N31VKK |
| SCHEMBL13491700 |
| UNII-NWQ5N31VKK |
US Patents and Regulatory Information for CUBICIN RF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cubist Pharms Llc | CUBICIN RF | daptomycin | POWDER;INTRAVENOUS | 021572-003 | Jul 6, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Cubist Pharms Llc | CUBICIN RF | daptomycin | POWDER;INTRAVENOUS | 021572-003 | Jul 6, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Cubist Pharms Llc | CUBICIN RF | daptomycin | POWDER;INTRAVENOUS | 021572-003 | Jul 6, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for CUBICIN RF
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,835,382 | Lipopeptide compositions and related methods | ➤ Try a Free Trial |
| 9,662,397 | Lipopeptide compositions and related methods | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for CUBICIN RF
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Singapore | 10201407724Y | ➤ Try a Free Trial |
| New Zealand | 600118 | ➤ Try a Free Trial |
| Dominican Republic | P2012000140 | ➤ Try a Free Trial |
| Chile | 2015002412 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for CUBICIN RF
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0022 | France | ➤ Try a Free Trial | PRODUCT NAME: DAPTOMYCINE; REGISTRATION NO/DATE: EU/1/05/328/001-002 20060119 |
| 22/2006 | Austria | ➤ Try a Free Trial | PRODUCT NAME: DAPTOMYCIN |
| 2006 00018 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: DAPTOMYCIN |
| /2006 | Austria | ➤ Try a Free Trial | PRODUCT NAME: DAPTOMYCIN; REGISTRATION NO/DATE: EU/1/05/328/001 UND 002 20060119 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
